Comment of the reviewer Prof
Several physiological factors may potentially contribute to tiredness in patients taking these medications
Clinical Studies 14.1 Glycemic Control in Adults with Type 2 Diabetes Mellitus Overview of Clinical Trials of FARXIGA in Adults with Type 2 Diabetes Mellitus FARXIGA has been studied in adult patients as monotherapy, in combination with metformin, pioglitazone, sulfonylurea (glimepiride), sitagliptin (with or without metformin), metformin plus a sulfonylurea, or insulin (with or without other oral antidiabetic therapy), compared to a sulfonylurea (glipizide), and in combination with a GLP-1 receptor agonist (exenatide extended release) added on to metformin
If possible, check whether your preferred pharmacy is in-network and whether they have the medication in stock
Treatment regimens followed best practice recommendations but naturally varied inter-individually, inducing potential bias